A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF THE EFFECTS OF DOCOSAHEXAE
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF THE EFFECTS OF DOCOSAHEXAE
批准号:
7951056
负责人:
RUTH MULNARD MCCARGAR
金额:
$0.96万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30
关键词:
Alzheimer&aposs DiseaseAlzheimer&aposs disease modelAmyloid beta-ProteinAnimalsAntioxidantsAssesBloodBrainCerebrospinal FluidClinical ResearchCognitiveComputer Retrieval of Information on Scientific Projects DatabaseDiet HabitsDietary intakeDocosahexaenoic AcidsEpidemiologic StudiesFundingGrantGray unit of radiation doseHippocampus (Brain)HumanIndividualInstitutionMemoryMicronutrientsMusOmega-3 Fatty AcidsPhospholipidsPlacebosPlasmaRandomizedRattusResearchResearch PersonnelResourcesSamplingSourceSupplementationTestingThinkingUnited States National Institutes of HealthUrinedouble-blind placebo controlled trialfunctional declinehuman subject
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
流行病学研究表明,在18个月的时间里,补充二十二碳六烯酸可以减缓轻到中度阿尔茨海默病患者S病(AD)认知和功能下降的进程。DHA是一种omega-3脂肪酸,已被证明可以降低AD模型小鼠和大鼠大脑中的β-淀粉样蛋白(A?)水平,并对脑脊液具有抗氧化作用。与对照组相比,阿尔茨海默病患者大脑前额叶灰质和海马磷脂中的DHA水平显著降低(如先前的人类研究所见),血浆中DHA的水平也显著降低。由于膳食摄入DHA可以增加受试者的血浆DHA水平,而且膳食摄入和血浆水平与动物的脑水平相关,因此补充DHA治疗AD是可行的,因此本研究提出了这一建议。
这项研究将通过实施记忆和思维测试,在18个月的时间里评估DHA与安慰剂在轻中度AD患者中的效果。这项研究还将收集血液和尿样,以检查与饮食习惯有关的微量营养素,这可能会揭示DHA的影响。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Epidemiological studies show that Docosahexaenoic Acid (DHA) supplementation slows the progression of cognitive and functional decline over 18 months in mild to moderate Alzheimer s Disease (AD). DHA, an omega-3 fatty acid has been shown to reduce brain levels of beta-amyloid (A¿) in mice and rat models of AD, as well as have antioxidant effects on the cerebrospinal fluid. Individuals with AD have significantly decreased brain levels of DHA in frontal grey and hippocampus phospholipids compared to controls (as seen in previous human studies), as well as significantly lower plasma levels of DHA compared to control subjects. Since dietary intake of DHA can increase plasma levels of DHA in human subjects, and since dietary intake and plasma levels correlate with brain levels in animals, treatment of AD with DHA supplementation is plausible, and thus proposed in this study.
This study will evaluate the effects of DHA versus placebo in subjects with mild to moderate AD over an 18 month period by administering memory and thinking tests. Blood and urine samples will also be collected in this study to examine the micronutrients related to dietary habits which may reveal DHA effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF THE EFFECTS OF DOCOSAHEXAE
-
批准号:8166913
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2009
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
MULTI-CENTER TRIAL TO EVALUATE HOME-BASED ASSESSMENT METHODS FOR ALZHEIMER DISEA
-
批准号:8166928
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2009
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
CLINICAL TRIAL: ESTROGEN PREVENTION TRIAL
-
批准号:7951032
-
项目类别:
-
资助金额:$0.68万
-
财政年份:2008
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
MULTI-CENTER TRIAL TO EVALUATE HOME-BASED ASSESSMENT METHODS FOR ALZHEIMER DISEA
-
批准号:7951076
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2008
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
CLINICAL TRIAL: STATIN TRIAL
-
批准号:7724991
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2007
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
CLINICAL TRIAL: HUPERZINE A TRIAL
-
批准号:7724997
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2007
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
CLINICAL TRIAL: PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLE
-
批准号:7725006
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2007
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
CLINICAL TRIAL: EVALUATION OF THE SAFETY, TOLERABILITY AND IMPACT ON BIOMARKERS
-
批准号:7725024
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2007
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
CLINICAL TRIAL: HOMOCYSTEINE TRIAL
-
批准号:7724992
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2007
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF THE EFFECTS OF DOCOSAHEXAE
-
批准号:7725039
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2007
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
PI PROTOCOL
-
批准号:7724994
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2007
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
CLINICAL TRIAL: ESTROGEN PREVENTION TRIAL
-
批准号:7724993
-
项目类别:
-
资助金额:$0.46万
-
财政年份:2007
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
EVALUATION OF THE SAFETY, TOLERABILITY AND IMPACT ON BIOMARKERS OF ANTI-OXIDANT
-
批准号:7606656
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2006
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
HUPERZINE A TRIAL
-
批准号:7374283
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2006
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
HOMOCYSTEINE TRIAL
-
批准号:7606619
-
项目类别:
-
资助金额:$0.62万
-
财政年份:2006
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
VALPROATE TRIAL
-
批准号:7374278
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2006
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
ESTROGEN PREVENTION TRIAL
-
批准号:7606620
-
项目类别:
-
资助金额:$0.54万
-
财政年份:2006
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
VALPROATE TRIAL
-
批准号:7606624
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2006
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
ESTROGEN PREVENTION TRIAL
-
批准号:7374273
-
项目类别:
-
资助金额:$0.68万
-
财政年份:2006
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
PI PROTOCOL
-
批准号:7606621
-
项目类别:
-
资助金额:$0.97万
-
财政年份:2006
-
负责人:RUTH MULNARD MCCARGAR
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: